|
|||
DRUGS & SUPPLEMENTS
|
How is the drug helping you? |
Ammonium Laurilsulfate:
Neutrogena Skin Clearing Foaming Wash (Ammonium Laurilsulfate) Lactate Lotion, 12% is indicated for the treatment of dry, scaly skin (xerosis) and ichthyosis vulgaris, and for the temporary relief of itching associated with these conditions.
Neutrogena Skin Clearing Foaming Wash (Ammonium Laurilsulfate) Lactate Lotion, 12% is contraindicated in those patients with a history of hypersensitivity to any of the label ingredients.
Sun exposure (natural or artificial sunlight) to areas of the skin treated with Neutrogena Skin Clearing Foaming Wash (Ammonium Laurilsulfate) Lactate Lotion, 12% should be minimized or avoided (see PRECAUTIONS). The use of Neutrogena Skin Clearing Foaming Wash (Ammonium Laurilsulfate) Lactate Lotion, 12% should be discontinued if any hypersensitivity is observed.
For external use only. Stinging or burning may occur when applied to skin with fissures, erosions, or that is otherwise abraded. Caution is advised when used on the face because of the potential for irritation. The potential for post-inflammatory hypo- or hyperpigmentation has not been studied.
Patients using Neutrogena Skin Clearing Foaming Wash (Ammonium Laurilsulfate) Lactate Lotion, 12% should receive the following information and instructions:
The topical treatment of CD-1 mice with 12%, 21% or 30% Neutrogena Skin Clearing Foaming Wash lactate formulations for two-years did not produce a significant increase in dermal or systemic tumors in the absence of increased exposure to ultraviolet radiation. The maximum systemic exposure of the mice in this study was 0.7 times the maximum possible systemic exposure in humans. However, a long-term photocarcinogenicity study in hairless albino mice suggested that topically applied 12% Neutrogena Skin Clearing Foaming Wash (Ammonium Laurilsulfate) lactate formulations enhanced the rate of ultraviolet light-induced skin tumor formation.
The mutagenic potential of Neutrogena Skin Clearing Foaming Wash (Ammonium Laurilsulfate) lactate formulations was evaluated in the Ames assay and in the mouse in vivo micronucleus assay, both of which were negative.
In dermal Segment I and III studies with Neutrogena Skin Clearing Foaming Wash (Ammonium Laurilsulfate) lactate formulations there were no effects observed in fertility or pre- or postnatal development parameters in rats at dose levels of 300 mg/kg/day (1800 mg/m2/day), approximately 0.4 times the human topical dose.
Animal reproduction studies have been performed in rats and rabbits at doses up to 0.7 and 1.5 times the human dose, respectively and have revealed no evidence of impaired fertility or harm to the fetus due to Neutrogena Skin Clearing Foaming Wash (Ammonium Laurilsulfate) lactate formulations. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, Neutrogena Skin Clearing Foaming Wash (Ammonium Laurilsulfate) Lactate Lotion, 12% should be used during pregnancy only if clearly needed.
Although lactic acid is a normal constituent of blood and tissues, it is not known to what extent this drug affects normal lactic acid levels in human milk. Because many drugs are excreted in human milk, caution should be exercised when Neutrogena Skin Clearing Foaming Wash (Ammonium Laurilsulfate) lactate is administered to a nursing woman.
Safety and effectiveness of Neutrogena Skin Clearing Foaming Wash lactate have been demonstrated in infants and children. No unusual toxic effects were reported.
Clinical studies of Neutrogena Skin Clearing Foaming Wash (Ammonium Laurilsulfate) lactate lotion, 12% did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. Other reported clinical experience has not identified differences in responses between elderly and younger patients. In general, dose selection for an elderly patient should be cautious.
The most frequent adverse experiences in patients with xerosis are transient stinging (1 in 30 patients), burning (1 in 30 patients), erythema (1 in 50 patients) and peeling (1 in 60 patients). Other adverse reactions which occur less frequently are irritation, eczema, petechiae, dryness, and hyperpigmentation. Due to the more severe initial skin conditions associated with ichthyosis, there was a higher incidence of transient stinging, burning and erythema (each occurring in 1 in 10 patients).
The oral administration of Neutrogena Skin Clearing Foaming Wash (Ammonium Laurilsulfate) lactate to rats and mice showed this drug to be practically non-toxic (LD50>15 mL/kg).
Shake well. Apply to the affected areas and rub in thoroughly. Use twice daily or as directed by a physician.
Neutrogena Skin Clearing Foaming Wash Lactate Lotion, 12% is available as follows:
225 g bottle (NDC 45802-419-54)
400 g bottle (NDC 45802-419-26)
Store at 20-25°C (68-77°F).
Manufactured By Perrigo, Bronx, NY 10457
Distributed By Perrigo, Allegan, MI 49010
0K5A7 RC F6
Rev 01-17
Salicylic Acid:
Neutrogena Skin Clearing Foaming Wash is pharmaceytical active ingredient for topical use. Inhibits the secretion of the sebaceous and sweat glands. At low concentrations it has keratoplastic and in high doses keratolytic effect. Neutrogena Skin Clearing Foaming Wash (Salicylic Acid) has a weak antimicrobial activity.
Monotherapy with Neutrogena Skin Clearing Foaming Wash (Salicylic Acid) and as part of combination therapies for inflammatory, infectious and other skin lesions, including burns, psoriasis, eczema, dyskeratosis, ichthyosis, acne vulgaris, warts, hyperkeratosis, corn, callus, oily seborrhea, scaly skin disease, hair loss, sweating feet.
Neutrogena Skin Clearing Foaming Wash is applied to the skin surface 2-3 times / day.
Rarely: local reactions such as itching, burning, skin rashes, allergic reactions.
Hypersensitivity to Neutrogena Skin Clearing Foaming Wash (Salicylic Acid), renal failure, infancy.
The composition of the solution for topical use include ethanol.
Neutrogena Skin Clearing Foaming Wash (Salicylic Acid) is pharmaceutically not compatible with resorcinol (forms melted mixture) and zinc oxide (forms insoluble forms of zinc salicylate).
Vitamin C (Ascorbyl Glucoside):
Indication: Used to treat Neutrogena Skin Clearing Foaming Wash (Vitamin C (Ascorbyl Glucoside)) deficiency, scurvy, delayed wound and bone healing, urine acidification, and in general as an antioxidant. It has also been suggested to be an effective antiviral agent.
Ascorbic Acid (vitamin C) is a water-soluble vitamin indicated for the prevention and treatment of scurvy, as ascorbic acid deficiency results in scurvy. Collagenous structures are primarily affected, and lesions develop in bones and blood vessels. Administration of ascorbic acid completely reverses the symptoms of ascorbic acid deficiency.
Vitamin E (Tocopherol Acetate):
Indication: Neutrogena Skin Clearing Foaming Wash (Vitamin E (Tocopherol Acetate)), known for its antioxidant activities, is protective against cardiovascular disease and some forms of cancer and has also demonstrated immune-enhancing effects. It may be of limited benefit in some with asthma and rheumatoid arthritis. It may be helpful in some neurological diseases including Alzheimer's, some eye disorders including cataracts, and diabetes and premenstrual syndrome. It may also help protect skin from ultraviolet irradiation although claims that it reverses skin aging, enhances male fertility and exercise performance are poorly supported. It may help relieve some muscle cramps.
Neutrogena Skin Clearing Foaming Wash (Vitamin E (Tocopherol Acetate)) has antioxidant activity. It may also have anti-atherogenic, antithrombotic, anticoagulant, neuroprotective, antiviral, immunomodulatory, cell membrane-stabilizing and antiproliferative actions. Neutrogena Skin Clearing Foaming Wash (Vitamin E (Tocopherol Acetate)) is a collective term used to describe eight separate forms, the best-known form being alpha-tocopherol. Neutrogena Skin Clearing Foaming Wash (Vitamin E (Tocopherol Acetate)) is a fat-soluble vitamin and is an important antioxidant. It acts to protect cells against the effects of free radicals, which are potentially damaging by-products of the body's metabolism. Neutrogena Skin Clearing Foaming Wash (Vitamin E (Tocopherol Acetate)) is often used in skin creams and lotions because it is believed to play a role in encouraging skin healing and reducing scarring after injuries such as burns. There are three specific situations when a Neutrogena Skin Clearing Foaming Wash (Vitamin E (Tocopherol Acetate)) deficiency is likely to occur. It is seen in persons who cannot absorb dietary fat, has been found in premature, very low birth weight infants (birth weights less than 1500 grams, or 3½ pounds), and is seen in individuals with rare disorders of fat metabolism. A Neutrogena Skin Clearing Foaming Wash (Vitamin E (Tocopherol Acetate)) deficiency is usually characterized by neurological problems due to poor nerve conduction. Symptoms may include infertility, neuromuscular impairment, menstrual problems, miscarriage and uterine degradation. Preliminary research has led to a widely held belief that Neutrogena Skin Clearing Foaming Wash (Vitamin E (Tocopherol Acetate)) may help prevent or delay coronary heart disease. Antioxidants such as Neutrogena Skin Clearing Foaming Wash (Vitamin E (Tocopherol Acetate)) help protect against the damaging effects of free radicals, which may contribute to the development of chronic diseases such as cancer. It also protects other fat-soluble vitamins (A and B group vitamins) from destruction by oxygen. Low levels of Neutrogena Skin Clearing Foaming Wash (Vitamin E (Tocopherol Acetate)) have been linked to increased incidence of breast and colon cancer.
Depending on the reaction of the Neutrogena Skin Clearing Foaming Wash after taken, if you are feeling dizziness, drowsiness or any weakness as a reaction on your body, Then consider Neutrogena Skin Clearing Foaming Wash not safe to drive or operate heavy machine after consumption. Meaning that, do not drive or operate heavy duty machines after taking the capsule if the capsule has a strange reaction on your body like dizziness, drowsiness. As prescribed by a pharmacist, it is dangerous to take alcohol while taking medicines as it exposed patients to drowsiness and health risk. Please take note of such effect most especially when taking Primosa capsule. It's advisable to consult your doctor on time for a proper recommendation and medical consultations.
Is Neutrogena Skin Clearing Foaming Wash addictive or habit forming?Medicines are not designed with the mind of creating an addiction or abuse on the health of the users. Addictive Medicine is categorically called Controlled substances by the government. For instance, Schedule H or X in India and schedule II-V in the US are controlled substances.
Please consult the medicine instruction manual on how to use and ensure it is not a controlled substance.In conclusion, self medication is a killer to your health. Consult your doctor for a proper prescription, recommendation, and guidiance.
There are no reviews yet. Be the first to write one! |
The information was verified by Dr. Rachana Salvi, MD Pharmacology